The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM; appt. of Ben Procter as CFO and COO

10 May 2023 13:26

RNS Number : 9855Y
Cenkos Securities PLC
10 May 2023
 

 

10 May 2023

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Result of AGM; appointment of Ben Procter as CFO and COO

 

 

At Cenkos' annual general meeting held earlier today (the "AGM"), all resolutions proposed were duly passed.

 

Further to previous announcements on 24 March 2023 and 5 December 2022, with effect from the conclusion of today's AGM, Ben Procter has joined the Board as Chief Financial Officer, Chief Operating Officer and as an executive director of the Company.

 

Disclosure requirements pursuant to the Takeover Code

 

The disclosures below are being made pursuant to the requirements of the Takeover Code and defined terms in this announcement shall have the meanings set out in the scheme document published by Cenkos dated 20 April 2023.

 

Under the terms of an executive service agreement dated 9 May 2023, Ben Procter is paid an annual base salary of £250,000. He is eligible to receive an additional discretionary bonus. He is also entitled to a pension contribution on a statutory minimum basis based on qualifying earnings and will receive life assurance and private medical insurance. He is also eligible for cover under any director or officer insurance that Cenkos maintains from time to time.

 

Under his service agreement, his employment may be terminated by either party providing written notice to the other of not less than six months. Cenkos has the ability to make a payment in lieu of notice equal to the base salary and benefits element of his remuneration for any unexpired portion of the notice period. Cenkos also reserves the right to place him on garden leave during his notice period (for all or an element of the notice period). Cenkos is also entitled to dismiss him without notice in certain circumstances such as serious misconduct or following a serious breach of his duties. The service agreement also contains six-month non-competition and six-month non-solicitation post-termination restrictive covenants.

 

As at the date of this announcement, none of Ben nor any close relative, related trust or connected person of Ben has borrowed or lent, or has a Note 11 arrangement with any other person, or has any interest in, right to subscribe in respect of, or short position in relation to, relevant Cenkos securities other than a contractual right pursuant to his offer letter dated 14 October 2022 to be awarded 317,461 Cenkos Shares in lieu of unvested cash and share awards from his previous employer to vest equally in April 2024, 2025 and 2026. It is intended that this award will be made prior to the Effective Date of the Scheme.

 

As at the date of this announcement, none of Ben nor any close relative, related trust or connected person of Ben has dealt in any relevant Cenkos securities during the Offer Period.

 

As at the date of this announcement, none of Ben nor any close relative, related trust or connected person of Ben has borrowed or lent, or has a Note 11 arrangement with any other person, or has any interest in, right to subscribe in respect of, or short position in relation to, relevant finnCap securities, and no such person has dealt in any relevant finnCap securities during the Offer Period.

 

Save as disclosed above:

 

(i) Ben is not entitled to any commission or profit-sharing arrangements;

 

(ii) other than statutory compensation and payment in lieu of notice, no compensation is payable to Ben upon early termination of his contract or appointment;

 

(iii) there are no service contracts or letters of appointment between Ben and any member of the Cenkos Group and no such contract has been entered into or amended within the six months preceding the date of this announcement; and

 

(iv) the effect of the Scheme on the interests of Ben Procter does not differ from its effect on the like interests of any other holder of Scheme Shares.

 

For further information, please contact:

 

Cenkos Securities plc

Julian Morse, Chief Executive Officer Tel: 020 7397 8900

 

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser Tel: 020 3368 3552

 

Additional information

 

In accordance with AIM Rule 17 and Schedule 2 paragraph (g) of the AIM Rules, further information required to be disclosed in relation to Ben Procter is set out here:

 

Full name and age:

Ben Procter aged 51

 

Current Directorships/Partnerships:

None

 

Previous Directorships/Partnerships over the past five years:

None

 

Current shareholding in the Company:

None

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGMZGMKZGNGFZM
Date   Source Headline
10th Mar 202110:23 amRNSForm 8.5 (EPT/NON-RI)
9th Mar 20218:27 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 20218:44 amRNSForm 8.5 (EPT/NON-RI)
5th Mar 20218:59 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 20218:43 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 20219:22 amRNSForm 8.5 (EPT/NON-RI)
26th Feb 20219:44 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 20218:23 amRNSForm 8.5 (EPT/NON-RI)
24th Feb 20218:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 202110:57 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 202110:51 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 202110:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 20218:28 amRNSForm 8.5 (EPT/NON-RI)
19th Feb 20218:32 amRNSForm 8.5 (EPT/NON-RI)
18th Feb 20218:29 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 20219:11 amRNSForm 8.5 (EPT/NON-RI)
12th Feb 20219:21 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20219:26 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 20219:54 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 20218:16 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20218:26 amRNSForm 8.5 (EPT/NON-RI)
5th Feb 20218:39 amRNSForm 8.5 (EPT/NON-RI)
3rd Feb 20218:07 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 20219:20 amRNSForm 8.5 (EPT/NON-RI)
29th Jan 20219:22 amRNSForm 8.5 (EPT/NON-RI)
28th Jan 20218:36 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20218:53 amRNSForm 8.5 (EPT/NON-RI)
26th Jan 20219:47 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20218:18 amRNSForm 8.5 (EPT/NON-RI)
22nd Jan 20218:42 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20219:10 amRNSForm 8.5 (EPT/NON-RI)
20th Jan 20218:56 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20218:15 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20218:06 amRNSForm 8.5 (EPT/NON-RI)
14th Jan 20219:11 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20218:40 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20219:08 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 202110:22 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 20218:28 amRNSForm 8.5 (EPT/NON-RI)
6th Jan 20218:23 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 20219:13 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20214:34 pmRNSEBT Share Purchase Plan
31st Dec 202011:36 amRNSForm 8.5 (EPT/NON-RI)
29th Dec 20208:25 amRNSForm 8.5 (EPT/NON-RI)
21st Dec 20208:57 amRNSForm 8.5 (EPT/NON-RI)
17th Dec 20208:59 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 20208:43 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 20208:49 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20209:54 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 20208:34 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.